However, many patients with T2DM being treated with oral hypoglycemic agents and reporting poor glycemic control are often reluctant to receive insulin treatment (Lee, 2015; Polonsky, Hajos, Dain, & Snoek, 2011). The gene discussed is INS; the disease is type 2 diabetes mellitus.